Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CVS To Close 200-225 Eckerd Stores; Number Is Fewer Than Expected, Retailer Says

This article was originally published in The Pink Sheet Daily

Executive Summary

The chain has held “introductory meetings” with Eckerd workers; the acquisition of 1,260 stores is expected to close in June. The Eckerd Health Services PBM could help revitalize CVS’ PharmaCare division, which experienced flat growth in the first quarter.

You may also be interested in...



CVS Renames ProCare

CVS is changing the name of its specialty pharmacy business CVS ProCare to PharmaCare Specialty Pharmacy

CVS Doubles PBM Business Through $2.2 Bil. Eckerd Deal

CVS sees the acquisition of Eckerd Health Services as key to luring larger corporate PBM customers. The acquisition of 1,260 Eckerd pharmacies also makes CVS the number one U.S. pharmacy retailer in store count, with over 5,000 outlets.

COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers

First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.

Topics

UsernamePublicRestriction

Register

LL1134531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel